Industries > Pharmaceutical/Biotech | SupplyChainBrain
Advertise
Contact Us
Supplier Directory
Events
LinkedIn icon
Twitter X icon
YouTube icon
Facebook icon
Search Site
Login
Subscribe
SCB Features
Podcasts
Webinars
Upcoming Webinars
On Demand Webinars
Webinar Library
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Whitepapers
Pharmaceutical/Biotech: Page 3
How AstraZeneca Built Constraint-Based Planning With OMP
AstraZeneca selected supply chain planning software provider OMP to help redefine the biopharmaceutical giant's global planning capabilities.
EU Votes to Move Ahead with U.S. Trade Deal
Under the agreed provisions, the EU will cut tariffs to zero on American industrial goods, and the U.S. will keep tariffs on many European goods at around 15%
Fire at California Warehouse Threatens West Coast Medical Supplies
Fire officials say that they're currently coordinating with Medline to allow the company to access supplies at the warehouse that weren't damaged in the fire.
Trump Begins Rebuilding His Tariff Wall Citing Forced Labor
Section 301 tariffs are seen as more legally sound and flexible than other powers Trump has eyed, but also more time-consuming.
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent
China’s biotech sector is booming, but its growth has coincided with backlash from the U.S.
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
India is the first market where Novo Nordisk faces generic competition for semaglutide — the active ingredient in Ozempic and Wegovy.
From Needles to Pills: GLP-1 Supply Chains Face a New Stress Test
Oral GLP-1s are set to shake up the weight-loss drug market, but industry onlookers will be wondering how these new tablets might impact healthcare supply chains.
Watch: Seeking Visibility: A New Pharmacy Survey From Tecsys
Tecsys's new pharmacy survey unveils a serious lack of supply chain visibility in an industry that needs it more than ever. Guy Courtin, vice president industry and global alliances, explains.
Truckload Carriers Warn of ‘Unintended Consequences’ of Marijuana Reclassification
The TCA called for the passage of a bill that would require positive hair test results be included in the federal clearinghouse.
Japan to Offer Subsidies in Southeast Asia to Counter Oil Prices
Takaichi announced the initiative at a regional forum that included Japan and major Southeast Asian economies such as Thailand, Vietnam, the Philippines and Malaysia.
The Hidden Supply Chain Complexity Behind Fragrance Products
The fragrance industry, once dominated by alcohol-based sprays packaged in glass bottles, is expanding to include oils, balms, solids, aerosols and other alternative formats that fall under hazmat regulations.
Trump Will Impose 100% Tariff on Some Patented Drugs
The charges deliver on threats the president made last fall to impose 100% tariffs on branded or patented medicines unless companies move production to the U.S.
Previous Page
Page 3 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
By submitting this form, you acknowledge that use of your data is governed by our
Privacy Policy.
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site